Video Lectures from Keane's Corner

Personalized Therapy with Erdafitinib: A Biomarker-Targeted Therapy for Urothelial Cancer - Arlene Siefker-Radtke

August 26, 2020

Details

The Oral GnRH Receptor Antagonist Relugolix as Neoadjuvant/Adjuvant ADT to EBRT in Patients with Intermediate-risk Prostate Cancer - Thomas Keane

August 24, 2020

Details

PROfound: Olaparib for Metastatic Castrate Resistant Prostate Cancer - Thomas Keane

July 2, 2020

Details

AUA 2020 Review: Genomic Heterogeneity in Tissue-Based Prognostic Signatures from Prostate Biopsies: The Results From Two Prospective Trials - Thomas Keane

June 25, 2020

Details

AUA 2020 Review: Using Biomarkers in Patients with a Positive Multiparametric MRI: 4Kscore Predicts Presence of Cancer Outside the Index Lesion - Thomas Keane

June 25, 2020

Details

Developments in Imaging Prior to Biopsy — Are Systematic Biopsies Still Required - Tom Keane

January 27, 2020

Details

KEYNOTE-057 in High-Risk, Non-Muscle Invasive Bladder Cancer: Trial Highlights by Tom Keane

December 7, 2018

Details

Effectiveness of Radical Prostatectomy with Adjuvant Radiotherapy versus Radiotherapy Plus ADT for Men with Advanced Prostate Cancer - Tom Keane

November 30, 2018

Details

CARMENA in mRCC and Surgical Management Cases in Bladder Cancer from ASCO 2018 - Tom Keane

June 23, 2018

Details

Prostate Cancer Highlights from AUA 2018 with Tom Keane

June 13, 2018

Details

The Changing Landscape in Advanced Bladder Cancer - Tom Keane

April 19, 2018

Details

New Concepts in ADT- Thomas Keane

April 8, 2018

Details

Discussion of an Online Tool to Explore Evolving Practice Patterns in Renal Cell Carcinoma - Thomas Keane

February 22, 2018

Details

Discussion of the IMmotion 151 Trial: Atezolizumab Plus Bevacizumab vs Sunitinib in Untreated Metastatic Renal Cell Carcinoma - Thomas Keane

February 22, 2018

Details

Discussion of the CABOSUN trial - Advanced Renal Cell Carcinoma - Thomas Keane

February 21, 2018

Details

Discussion on FALCON: Impact of 18F-fluciclovine PET/CT on Clinical Management Choices for Men with Biochemically Recurrent Prostate Cancer

February 15, 2018

Details

Discussion on SPARTAN: A Study of Apalutamide in Men with Non-Metastatic Castration-resistant Prostate Cancer - Thomas Keane

February 14, 2018

Details

News Update: Apalutamide as a Treatment for Non-Metastatic Castration-Resistant Prostate Cancer - Thomas Keane

January 3, 2018

Details

Review of SIU-ICUD Joint Consultation on Bladder Cancer - Thomas Keane

December 14, 2017

Details

Prostate Cancer Highlights from SUO 2017 - Thomas Keane

December 14, 2017

Details

Bladder Cancer Highlights from SIU 2017 - Thomas Keane

November 22, 2017

Details

Role of MRI in Men on Active Surveillance - Laurence Klotz

November 14, 2017

Details

Discussion on the AQUARiUS and EXCAAPE studies- Thomas Keane

October 15, 2017

Details

ESMO 2017: Prostate Cancer Highlights

October 9, 2017

Details

STAMPEDE and LATITUDE Trials: Issues to Consider - Thomas Keane

August 1, 2017

Details

Evolution of the Mesh Problem - Eric Rovner

June 27, 2017

Details

ASCO 2017: Discussion of LATITUDE and STAMPEDE Trials

June 9, 2017

Details

Active Surveillance: Protecting Patients From Harm- Laurence Klotz

June 2, 2017

Details

Tom Keane Highlights Notable SUO 2016 Presentations

February 1, 2017

Details

SIU 2016: 36th Congress Highlights

November 30, 2016

Details

Journal Club: Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormones Agonist and an Antagonist

September 27, 2016

Details

Role of the Gonadotrophin-Releasing Hormone Antagonists and Advanced Hormone-Dependent Prostate Cancer - Journal review

September 9, 2016

Details

Cardiovascular Effects of Androgen Deprivation Therapy for the Treatment of Prostate Cancer

September 14, 2016

Details

ASCO 2016: Keane's Corner blog - Bladder Cancer.

June 22, 2016

Details

AUA 2016 Roundup: Prostate Cancer

June 17, 2016

Details

AUA 2016 Round Up: Bladder Cancer

June 1, 2016

Details

EAU 2016 - GU Oncology Highlights part 2

April 26, 2016

Details

Focus on ASCO GU 2016

April 1, 2016

Details

2016 ASCO GU: Renal Cancer Review

February 11, 2016

Details

2016 ASCO GU: Prostate Cancer Conference Highlights

February 11, 2016

Details

2015 Uro-Oncology Highlights - "What we have learned in the past year"

January 6, 2016

Details

Impact of the CCP Test on Physician and Patient Treatment Selection

November 4, 2015

Details

Perspectives - Releasing the Brakes on Cancer Immunotherapy

October 2, 2015

Details

The Dose-Dependent Effect Of ADT For Localized Prostate Cancer On Adverse Cardiac Events

July 29, 2015

Details

ASCO 2015 - Docetaxel and/or Zoledronic Acid for Hormone-naïve Prostate Cancer

June 22, 2015

Details

ASCO 2015 - Prostate & Bladder Cancers

June 29, 2015

Details

ASCO 2015 - Optimal Timing of Docetaxel for Metastatic Prostate Cancer

June 4, 2015

Details

GU Cancers Symposium 2015 - Prostate Cancer

April 27, 2015

Details

Biopsy and Re-biopsy of the Prostate: Interview with E. David Crawford, MD

April 13, 2015

Details

GU Cancers Symposium 2015 - Renal & Prostate Cancers

March 23, 2015

Details

GU Cancers Symposium 2015 - Prostate Cancer

March 6, 2015

Details

Comparison of MR/Ultrasound Fusion-guided Biopsy with Ultrasound-guided Biopsy for PCa

February 18, 2015

Details

Review of Recent Prostate Cancer Trial Results - January 2015

February 3, 2015

Details

Review of Highlights from 2014

January 20, 2015

Details

The Role of GDF-15 Expression and Vitamin D in the Prostate

November 12, 2014

Details

Practical Guide to Radium-223 in mCRPC

October 27, 2014

Details

Practical Guide to the use of Abiraterone in CRPC

October 20, 2014

Details

Practical Guide to Immunotherapy in CRPC

October 13, 2014

Details

Keane's Commentary - Results from ERSPC at 13 Years of Follow-up

October 6, 2014

Details

Most PCa Specialists Believe AS in Low-risk PCa is Effective and Underused

August 26, 2014

Details

Rates of Mgmt of Low-risk PCa with Observation Varies Widely Across Urologists and Rad Oncs

August 4, 2014

Details

Men with PCa and Recent Dx of Depression Less Likely to Undergo Definitive Tx & Experience Worse OS

July 28, 2014

Details

Primary ADT not Associated with Improved OS for Localized PCa

July 21, 2014

Details

Prostate Cancer Poster Session SES AUA 2014

April 3, 2014

Details

Perspectives from the Editor-in-Chief - March 2014

March 16, 2014

Details

Keane's Corner - February 2014

February 7, 2014

Details

Keane's Corner - December 2013

December 17, 2013

Details

Keane's Corner - October 2013

October 29, 2013

Details